Soluble epidermal growth factor receptor (EGFR) and HER-2 monitoring in a Phase II combination of gefitinib (ZD1839) and docetaxel for non-small-cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7090 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7090-7090

Author(s):

M. P. Gatineau ◽

E. Dansin ◽

F. Chomy ◽

E. Lemarie ◽

P. Nouyrigat ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Her 2 ◽

Epidermal Growth

Download Full-text

Soluble epidermal growth factor receptor (EGFR) and HER-2 monitoring in a Phase II combination of gefitinib (ZD1839) and docetaxel for non-small-cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7090 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7090-7090

Author(s):

M. P. Gatineau ◽

E. Dansin ◽

F. Chomy ◽

E. Lemarie ◽

P. Nouyrigat ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Her 2 ◽

Epidermal Growth

Download Full-text

Faculty Opinions recommendation of Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1018878.217464 ◽

2004 ◽

Author(s):

Joachim Herz

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Activating Mutations ◽

Epidermal Growth

Download Full-text

529 The role of aromatase and epidermal growth factor receptor in non-small cell lung cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)71330-6 ◽

2010 ◽

Vol 8 (5) ◽

pp. 135

Author(s):

I. Kritikou ◽

E. Giannopoulou ◽

A. Koutras ◽

K. Dimitropoulos ◽

H. Kalofonos

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

397 Epidermal Growth Factor Receptor (EGFR) Expression Levels Predict Cetuximab Activity in Non-small-cell Lung Cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)72195-0 ◽

2012 ◽

Vol 48 ◽

pp. 121

Author(s):

C. Stroh ◽

E. Staub ◽

M. Friese-Hamim ◽

S. Störkel ◽

C. Amendt

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Egfr Expression ◽

Epidermal Growth

Download Full-text

Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(89)90104-9 ◽

1989 ◽

Vol 5 (2-3) ◽

pp. 108

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer

Cancer Science ◽

10.1111/cas.12081 ◽

2013 ◽

Vol 104 (3) ◽

pp. 291-297 ◽

Author(s):

Koichi Hagiwara ◽

Kunihiko Kobayashi

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Receptor Gene ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

How do gefitinib and afatinib compare with other cytotoxic chemotherapy regimens for treatment of people with advanced epidermal growth factor receptor mutation non-small-cell lung cancer?

Cochrane Clinical Answers ◽

10.1002/cca.1893 ◽

2017 ◽

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Cytotoxic Chemotherapy ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)

OncoTargets and Therapy ◽

10.2147/ott.s100650 ◽

2017 ◽

Vol Volume 10 ◽

pp. 1757-1766 ◽

Author(s):

Nibal Saad ◽

Aarati Poudel ◽

Alina Basnet ◽

Ajeet Gajra

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

T790m Mutation ◽

Epidermal Growth

Download Full-text

Clinical impact of minocycline on afatinib-related rash in patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations

Respiratory Investigation ◽

10.1016/j.resinv.2017.11.009 ◽

2018 ◽

Vol 56 (2) ◽

pp. 179-183 ◽

Author(s):

Ayano Goto ◽

Yuichi Ozawa ◽

Keigo Koda ◽

Daisuke Akahori ◽

Takashi Koyauchi ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Clinical Impact ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

Oncology ◽

10.1159/000362603 ◽

2014 ◽

Vol 87 (4) ◽

pp. 215-223 ◽

Author(s):

Satoshi Igawa ◽

Masashi Kasajima ◽

Mikiko Ishihara ◽

Michiko Kimura ◽

Yasuhiro Hiyoshi ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text